Las Vegas, Nevada (May 11, 2016) GOOD NEWS! says UMAX
CEO. New Fiscal year promises stock growth and new, profitable
partnerships-all signaling UMAX turnaround!
Las Vegas, NV -- May 11, 2016 -- InvestorsHub NewsWire --
The CEO quotes, Good News! The fiscal year is completed for UMAX
Group Corp. UMAX will move forward completing its audit and S1
filing. These events trigger investment agreements signed with
Blackbridge Capital, an NYC leading alternative investment fund
offering a $10 million dollar EZ pass investment tool that will
allow UMAX Corp continued growth and investment capital to sustain
stock growth once again.
Currently, Thermalinx, a subsidiary of UMAX Corp, is proving to
be highly promising as it generates greater revenues and as efforts
continue to develop a medical (SAAS), software as a service for
thermal imaging soft-tissue health scoring. Development is
progressing with cloud-based and mobile apps that are robust and
HIPAA compliant. More information is available at upon written
request. The official launch is expected before the beginning of
summer but already interest in new SAAS and thermal imaging
technology is intensifying among prospective clinical end-users and
investors alike. Thermalinx services offer thermal imaging and an
overall medical, health-score that is generated through the
proprietary software. The thermal image coupled with the health
software create a fixed health score specific for the current
physiological condition of a patients soft-tissue. The findings are
reported to the patients medical practitioner for review and health
care recommendations. While outside interest builds, Thermalinx is
finalizing development of upcoming training programs designed for
medical professionals who will run Thermalinx Clinics.
In addition, UMAX is happy to announce negotiations with a
sovereign Native American nation, Tribal Clinic. Facilitating
alternative medicine, such as stem cell therapy, the Native
American Clinics provide opportunities and protections to the
patients, the medical practitioner and/or the researcher who seeks
alternative medical options inside the United States. Strategic
partnerships between the clinics, medical professionals and UMAX
allow research in alternative medicine and advances within the
Native Clinics. To date, Native American Clinics have enjoyed
rights of self-determined sovereignty on lands belonging to, or
attached to, Native American Tribes. This benefits the Native Tribe
and outside visitors who do not wish, nor can afford to travel
overseas to receive alternative medical treatment. Treatment at
Native American Clinics is much more affordable while benefiting
its visitors; more importantly, the Tribal foundation maintains
sovereign status and immunity from federal and state regulatory
oversight agencies. Stem Cell research and therapy is a prime
example why Thermalinx and UMAX is interested in this relationship
and other ancillary opportunities for revenue through medical
services. Utilizing the software and imaging as validation
protocols to establish immediate results based on validation of
protocol and procedures.
Ian Dixon, UMAX CEO says, Thermalinx will prepare the health
pre-screening and then our medical partners, at the Native American
Clinic, will prepare the comprehensive treatment plan focused on
healing the patient as opposed to managing symptoms of disease.
Says, Dixon, we see growth into 2017 and the funding of clinics on
both east and west coasts including strategically located clinics
between coasts. This will allow motivated medical tourists, within
the United States, to receive desired alternative medical care,
without having to leave the USA.
Finally, UMAX has a bright and exciting future. Special
investment opportunities are available now, in the form of a direct
PIPE investment (Private Investment in a Public Entity) Preferred
Stock. UMAX Investors, working under prospectus terms, will benefit
by investing in the pipe (preferred stock) however, only Accredited
investors may participate and help UMAX increase alternative
medicine clinics starting with Las Vegas area, Information is
available by contacting UMAX Corporation at (619) 368 2334 Utah
Time Zone or info@umaxcorp.com
Forward Looking Statement
Certain statements that we make may constitute forward-looking
statements under the Private Securities Litigation Reform Act of
1995. Forward-looking statements include information concerning
future strategic objectives, business prospects, anticipated
savings, financial results (including expenses, earnings,
liquidity, cash flow and capital expenditures), industry or market
conditions, demand for and pricing of our products, acquisitions
and divestitures, anticipated results of litigation and regulatory
developments or general economic conditions. In addition,
words such as believes, expects, anticipates, intends, plans,
estimates, projects, forecasts, and future or conditional verbs
such as will, may, could, should, and would, as well as any other
statement that necessarily depends on future events, are intended
to identify forward-looking statements. Forward-looking statements
are not guarantees, and they involve risks, uncertainties and
assumptions. Although we make such statements based on
assumptions that we believe to be reasonable, there can be no
assurance that actual results will not differ materially from those
expressed in the forward-looking statements. We caution
investors not to rely unduly on any forward-looking statements and
urge you to carefully consider the risks described in our filings
with the Securities and Exchange Commission from time to time,
including our most recent Annual Report and subsequent Flings,
which are available on Otcmarkets.com. We expressly disclaim any
obligation to update any forward-looking statement in the event it
later turns out to be inaccurate, whether as a result of new
information, future events or otherwise.
